BMC Pediatrics | |
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital | |
Seyed Taher Esfahani1  Leila Khedmat2  Daryoosh Fahimi3  Arash Abbasi3  Azadeh Afshin3  Sayed Yousef Mojtahedi3  Behnaz Bazargani3  Zahra Noparast3  Mastaneh Moghtaderi3  | |
[1] Department of Pediatrics, Division of Nephrology, Children’s Hospital Medical Center, Tehran University of Medical Sciences;Health Management Research Center, Baqiyatallah University of Medical Sciences;Pediatric Chronic Kidney Disease Research Center, The Children’s Hospital Medical Center, Tehran University of Medical Sciences; | |
关键词: Rituximab; Nephrotic syndrome; Pediatrics; Steroid dependent nephrotic syndrome; Steroid resistant nephrotic syndrome; | |
DOI : 10.1186/s12887-022-03109-4 | |
来源: DOAJ |
【 摘 要 】
Abstract Background There are controversy results in the optimal management of children with steroid-dependent and steroid-resistant nephrotic syndrome (SDNS, SRNS). This study aimed to determine the efficacy and safety of rituximab (RTX) in these pediatric patients. Methods Medical records of 1–18-year-old Iranian children with SDNS (n = 26) and SRNS (n = 22) with a follow-up for at least 24 months were included from 2009 to 2019. The short- and long-term responses to RTX were respectively evaluated to determine the random protein-to-creatinine ratio after 6 and 24 months and classified as complete (CR) and partial (PR) remission or no response. Results Male patients (n = 26) were slightly predominate. The median age of patients at the time of RTX therapy was 8.6 ± 4.01 years. At the end of the 6-month follow-up, CR and PR occurred in 23 (47.9%) and 12 (25%) patients, respectively. Of 23 patients with CR, 18 (69.2%) and 5(22.7%) had SDNS and SRNS, respectively (p < 0.005). However, only 18 (37.5%) of patients after 24 months had been in CR. No significant difference in the CR rate was found between the two groups. RTX was more effective when administered during the proteinuria-free period (p = 0.001). Conclusion In the short term, RTX significantly was efficient in inducing complete or PR in SDNS and SRNS patients. However, the favorable response rate in a long-term follow-up was insignificantly lower between the two groups.
【 授权许可】
Unknown